FindTrial
Sign In

The effect of discontinuation of aspirin on complication of inguinal hernia surgery

The effect of discontinuation of aspirin on complications of inguinal hernia surgery in patients receiving aspirin

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171213037857N2
Enrollment
100
Registered
2018-11-30
Start date
2018-06-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Inguinal hernia

Interventions

Intervention 1: Intervention group: Aspirin 80 mg will be discontinued (Jalinous, Iran) 7 days before surgery. Intervention 2: Control group: 80 mg Aspirin (Jalinous, Iran) single dose is prescribed

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inguinal hernia Age over 18 years old Daily aspirin therapy

Exclusion criteria

Exclusion criteria: Patients with unstable angina Congestive Heart Failure Shock Aspirin sensitivity History of gastrointestinal and cerebral hemorrhage Patients treated with warfarin, plavix and methotrexate

Design outcomes

Primary

MeasureTime frame
Bleeding. Timepoint: During the operation, Immediately after surgery. Method of measurement: Number of consumed gases.;Postoperative hematoma. Timepoint: 12 and 24 hours after surgery. Method of measurement: Clinical examination.;Postoperative complications. Timepoint: 7 days after surgery. Method of measurement: Clinical examination.;Postoperative pain. Timepoint: 4, 8, 12 hours after surgery. Method of measurement: Visual Analog Scale questionnaire.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shokoufeh Hassannia

Babol University of Medical Sciences

shokoufeh_hassannia@yahoo.com+98 11 3225 6285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026